Multimorbidity, living with two or more conditions is one of the biggest challenges facing patients and health systems today. It is increasing, driven by ageing and increasing inequalities.
Around one in four of the UK population have two or more chronic conditions while around 10% are estimated to have four or more conditions - a figure expected to double by 2035.
How we can help
Identifying comorbidity and multimorbidity clusters in patient groups and redesigning care pathways according to need
- Managing chronic diseases well vastly reduces the risk of illness, hospitalisation and/or death to patients and reduces costs for healthcare providers. Doing this requires careful management of a host of clinical and lifestyle risk factors, particularly as individuals living with just one chronic disease are becoming the exception rather than the norm. We map out clusters of chronic diseases in specific populations, patient groups and individuals.
- We examine how these patterns vary by a range of patient factors (including demographic, physiological and clinical risk factors) and over time, to assess how this impacts clinical outcomes and health system pressure. Our detailed approach helps implement personalised care pathways that optimise testing, treatment and specialist referrals to keep patients healthier longer.
Analysing patient groups with highest unmet need and forecasting burden of disease
- The prevalence of many chronic diseases has grown substantially yet the needs of patients vary greatly across chronic disease groups. We identify patient groups with highest unmet need of disease-specific complications and broader health need.
- We forecast burden of disease and patient demand for years to come in detail, bringing the data to life through interactive and dynamic visualisations rather than traditional approaches. This helps map out what trends mean for healthcare utilisation and costs with increasing granularity to inform advocacy, reimbursement negotiations and targeting patients at highest unmet need.
Health economics and outcomes research
- Estimating the cost-effectiveness of interventions (drugs or programmes) has been the bedrock of evidence-informed decision-making for years. In the era of multimorbidity, doing this on a disease-by-disease basis is often mismatched to the population's health needs and impacts. We estimate the health, economic and healthcare usage effects of given interventions on the index condition and its related multimorbidity in order to capture the wider perspective of health impacts across the health economy.
Our latest thinking
Explore our solutions
Explore our interactive tracker to see how waiting lists for NHS services vary across England.
Use our interactive visualisation to explore and compare key statistics for local authorities in England, including health, education, employment and economic administrative data.
See the health index in your area, how it has changed over time and compares to other local authorities.